Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

BCBA/RICH stock hub

BCBA/RICH has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BCBA/RICHis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

131.6B

Buenos Aires Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BCBA/RICH

In the news

Latest news · BCBA/RICH

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 14.1P50 17.9P75 19.4

Trailing P/E54.7

P25 25P50 30P75 39

ROE2.4

P25 6.8P50 15.6P75 45.1

ROIC2.6

P25 9P50 19.1P75 21.2

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BCBA/RICH market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

213

Groups with data

Currency

ARS

Showing 213 of 213 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Argentina
Country code	AR
Employees	620
Employees Change	0%
Employees Change Percent	0
Enterprise value	ARS 364.2B
Exchange	Buenos Aires Stock Exchange
Financial currency	ARS
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	ARLRIC300027
Last refreshed	2026-05-10
Market cap	ARS 131.6B
Price	ARS 1,620
Price currency	ARS
Rev Per Employee	204,396,375.47x
Sector	Healthcare
Sic	2834
Symbol	bcba/RICH
Website	https://www.richmondlab.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.35%
EV Earnings	117.95x
EV/EBIT	12.2x
EV/EBITDA	10.75x
EV/FCF	-10.14x
EV/Sales	2.87x
FCF yield	-27.29%
P/B ratio	1.41x
P/E ratio	54.75x
P/S ratio	1.04x
PE Ratio5 Y	29.69x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	23.6%
EBITDA Margin	26.04%
Gross margin	61.91%
Gross Profit	ARS 78.5B
Gross Profit Growth	19.22%
Gross Profit Growth3 Y	42.38%
Gross Profit Growth5 Y	76.76%
Net Income	ARS 3.1B
Net Income Growth	-90.16%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	82.39%
Net Income Growth5 Y	33.29%
Pretax Margin	6.4%
Profit Margin	2.44%
Profit Per Employee	ARS 5M
Profitable Years	2
ROA	4.9
Roa5y	5.42
ROCE	9.95
ROE	2.39
Roe5y	1.52
ROIC	2.61
Roic5y	6.79

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	17.13%
Cagr3y	57.88%
Cagr5y	45.57%
Div CAGR3	155.33%
Div CAGR5	117.32%
EPS Growth	-90.16
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth3 Y	82.41
EPS Growth5 Y	33.29
OCF Growth	-74.77%
Revenue Growth	4.95x
Revenue Growth Quarters	9x
Revenue Growth Years	2x
Revenue Growth3 Y	30.12x
Revenue Growth5 Y	68.5x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ARS 0.33
Assets	ARS 420.3B
Cash	ARS 15.3B
Current Assets	ARS 120.5B
Current Liabilities	ARS 119.8B
Debt	ARS 246.4B
Debt EBITDA	ARS 7.26
Debt Equity	ARS 2.65
Debt FCF	ARS -6.86
Equity	ARS 93B
Interest Coverage	2
Liabilities	ARS 327.3B
Long Term Assets	ARS 299.8B
Long Term Liabilities	ARS 207.5B
Net Cash	ARS -231B
Net Cash By Market Cap	ARS -176
Net Debt EBITDA	ARS 7
Net Debt Equity	ARS 2.48
Tangible Book Value	ARS 85.2B
Tangible Book Value Per Share	ARS 1,056
WACC	1.38

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.01
Inventory Turnover	1.29
Net Working Capital	ARS 45.2B
Quick ratio	0.65
Working Capital	ARS 742.3M
Working Capital Turnover	ARS 15.6

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0%
Dividend Growth	0%
Dividend Growth Years	4%
Dividend per share	ARS 26.89
Dividend Years	1
Dividend Yield	1.65%
Last Dividend	ARS 26.89
Payout Ratio	85.2%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	17.12%
200-day SMA	1,589.6
3Y total return	293.66%
50-day SMA	1,666.3
50-day SMA vs 200-day SMA	50over200
5Y total return	553.41%
All Time High	2,300
All Time High Change	-29.57%
All Time High Date	2025-12-11
All Time Low	24.8
All Time Low Change	6,432.26%
All Time Low Date	2018-07-02
ATR	77.44
Beta	-0.6
Beta1y	-0.17
Beta2y	-0.11
Ch YTD	-17.97
High	1,710
High52	2,300
High52 Date	2025-12-11
High52ch	-29.57%
Low	1,605
Low52	945
Low52 Date	2025-09-18
Low52ch	71.43%
Ma50ch	-2.78%
Price vs 200-day SMA	1.91%
RSI	47.89
RSI Monthly	56.79
RSI Weekly	46.36
Sharpe ratio	0.57x
Sortino ratio	1.07
Total Return	1.65%
Tr YTD	-17.97
Tr1m	-3.28%
Tr1w	-1.22%
Tr3m	-14.51%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ARS 29.9B
Operating Income Growth	50.28
Operating Income Growth3 Y	47.91
Operating Income Growth5 Y	66.62
Operating margin	23.6

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	14,167,164%
Net Borrowing	57,177,232,689
Shares Insiders	38.48%
Shares Institutions	0.06%
Shares Out	80,751,487
Shares Yo Y	-0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ARS -35.9B
Average Volume	4,536.7x
Bv Per Share	1,133
CAPEX	ARS -37.8B
Ch1m	-3.28
Ch1w	-1.22
Ch1y	14.89
Ch3m	-14.51
Ch3y	286.2
Ch5y	535.3
Ch6m	3.85
Change	1.25%
Change From Open	0.93
Close	1,600
Days Gap	0.31
Depreciation Amortization	3,093,737,493
Dollar Volume	17,750,340
Earnings Date	2026-05-14
EBIT	ARS 29.9B
EBITDA	ARS 33B
EPS	ARS 38.24
F Score	4
FCF	ARS -35.9B
FCF EV Yield	-9.86x
FCF Per Share	ARS -445
Financing CF	54,546,257,475
Fiscal Year End	December
Founded	1,959
Goodwill	5,694,078,398
Graham Number	987.35646
Graham Upside	-39.05
Income Tax	ARS 6B
Investing CF	-51,028,919,847
Is Primary Listing	1
Last Earnings Date	2025-11-07
Last Report Date	2025-12-31
Lynch Fair Value	ARS 956
Lynch Upside	-40.99
Ma150	1,703.1
Ma150ch	-4.88%
Ma20	1,630.5
Ma20ch	-0.64%
Net CF	2,239,522,729
Next Earnings Date	2026-05-14
Open	1,605
P OCF Ratio	70.53
Payment Date	2025-05-15
Position In Range	14.29
Ppne	246,266,517,338
Price Date	2026-05-08
Price EBITDA	ARS 3.99
Ptbv Ratio	1.54
Relative Volume	2.62x
Revenue	126,725,752,789x
Tax By Revenue	4.71x
Tax Rate	73.6%
Tr6m	3.85%
Volume	10,957
Z Score	0.84

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BCBA/RICH dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.6%

$26.9 annual per share

Payout ratio

+85.2%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+117.3%

4 consecutive years of growth

Total shareholder yield

+1.7%

Dividend yield + buyback yield combined

Performance

BCBA/RICH stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BCBA/RICH?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.1%

Share of float held by funds and institutions

Insider ownership

+38.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

BCBA/RICH momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.9

Neutral momentum band

Price vs 200-day MA

+1.9%

50/200-day relationship not available

Beta (5Y)

-0.60

Less volatile than the market

Sharpe ratio

0.57

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BCBA/RICH

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bcba/RICH stock rating?

bcba/RICH is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bcba/RICH analysis?

The full report lives at /stocks/bcba/RICH/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bcba/RICH?

The latest report frames bcba/RICH around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bcba/RICH page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.